Clara cells of mammalian airways have multiple functions and are morphologically heterogeneous. While Notch signaling is essential for the development of these cells, it is unclear how Notch influences Clara cell specification and if diversity is established among Clara cell precursors. Here we identify expression of the secretoglobin Scgb3a2 and Notch activation as early events in a program of secretory cell fate determination in developing murine airways. We show that Scgb3a2 expression in vivo is Notch-dependent at early stages, is ectopically induced by constitutive Notch1 activation, and that in vitro Notch signaling together with the pan-airway transcription factor Ttf1 (Nkx2.1) synergistically regulate secretoglobin gene transcription. Furthermore, we identified a novel subpopulation of secretory precursors juxtaposed to presumptive Neuroepithelial Bodies (NEBs), distinguished by their strong Scgb3a2 and Uroplakin3A (Upk3a) signals and reduced Ccsp (Scgb1a1) expression. Their association with NEBs is crucial, since genetic disruption of Ascl1 prevented NEB formation and selectively interfered with formation of this subpopulation of cells. Lineage labeling of Upk3A-expressing cells during development showed that these cells remain uncommitted during embryonic development and contribute to Clara and ciliated cells in the adult lung. Together our study suggests a role for Notch in the induction of a Clara cell-specific program of gene expression and reveals that the NEB microenvironment in the developing airways is a niche for a distinct subset of Clara-like precursors.
\body INTRODUCTION
The airways of the mammalian lung are populated by distinct epithelial cell types distinguished by their morphology and expression of molecular markers. Clara and ciliated cells are the most abundant while basal and neuroendocrine (NE) cells are restricted in number and distribution (1) . Clara cells synthesize components of the airway lining fluid, mediate mucociliary clearance in concert with ciliated cells, and metabolize environmental toxins. Furthermore, they act as facultative progenitor cells during lung injury-repair (1) (2) (3) .
Clara cells in the mouse lung have been distinguished in molecular terms by the expression of the secretoglobin Scgb1a1/Clara cell secretory protein (Ccsp or CC10). Subpopulations of Clara cells with distinctive morphology and susceptibility to environmental exposures have been reported in the mouse lung and in other species (4) . For example, ultrastructural analysis of conducting airways shows that Clara cells surrounding clusters of neuroepithelial cells (neuroepithelial bodies, NEBs) have a distinct flattened morphology (5) . These cells are also functionally distinct from other Clara cells as they are deficient in the cytochrome P450 enzyme Cyp2f2 (6) . It is thought that the absence of Cyp2f2 renders resistance to Naphthalene injury (6) .
Genetic studies in mice demonstrate an essential role for the Notch signaling in the specification of Clara cells during lung development (7, 8) . The Notch pathway is a juxtacrine signaling system that regulates cell fate choices in multiple biological systems (9) (10) (11) . The pathway is activated by the binding of transmembrane Notch receptors (Notch1-4) and transmembrane ligands Delta-like (Dll1, 3, 4) or Jagged (Jag1, Jag2). Ligand-receptor interaction results in gamma-secretase-dependent cleavage of the cytoplasmic domain of the Notch receptor. Nuclear translocation and interaction of this cleaved intracellular domain (NICD) with the Rbpjk transcriptional complex then leads to activation of a canonical pathway and the expression of target genes. Developing airways that are deficient in Rbpjk or Protein Ofucosyltransferase-1 (Pofut1), an enzyme required for the efficient binding of Notch receptor to ligand, lack Clara cells and have supernumerary ciliated cells (7, 8) . Conversely, constitutive activation in the developing lung epithelium results in mucous metaplasia and in a decrease in numbers of ciliated cells (12) .
Studies of the mechanisms of Clara cell specification and the role of Notch signaling therein have been limited by the paucity of early markers of differentiation. Transcription factors that label ciliated (Foxj1), neuroendocrine (Ascl1) and basal (Trp63) progenitors are known. However, with the exception of NICD, no nuclear factor specific to Clara cell progenitors has been identified. Hes1, a Notch transcriptional target, is expressed in developing airways, including Clara precursors, but it is not required for the specification of Clara cells (13) . Secretoglobins are a family of small, secreted, structurally similar disulfide-linked dimers of which three members, Ccsp (Scgb1a1), Scgb3a1 and Scgb3a2 are expressed in Clara cells in the lung (14) . At present, the secretoglobin Ccsp is the only definitive marker for Clara cells. Markers like Trp63, Ascl1 and Foxj1 have been localized to the developing airways E12.5 onwards. In contrast, Ccsp expression has been observed from E15.5 onwards (14) .
Here we examine the early events associated with the induction of Clara cell fate and the contribution of developmental programming in establishing differences among Clara cells in the mouse airway epithelium. We identify Scgb3a2 and activated Notch as markers of an early program of Clara cell fate. Moreover, we implicate Notch as a mediator of a Clara cell-specific program of gene expression in airway epithelial precursors. This program is modified in the developing NEB microenvironment to generate a distinct subpopulation of Clara cell precursors.
RESULTS

Notch activation in the developing airways precedes expression of known markers of airway differentiation.
Lineage analysis of cells that experienced Notch1 activation in the developing airways and loss-of-function genetic studies have shown that Notch signaling correlates with and is essential for the Clara cell fate (7, 8) . To characterize the spatio-temporal regulation of Notch signaling in the developing airways we examined the distribution of activated Notch1 by immunohistochemistry (IHC) using an antibody against cleaved Notch1 (hereafter NICD) (7) . NICD labeling was first detected in the respiratory epithelium at E12.5, at low levels, and restricted to the trachea and main bronchi ( Fig. 1A,B ). At E14.5 NICD-positive cells were more abundant in the proximal airways but absent in the distal airways ( Fig. 1C -E). At this stage strong NICD signals were detected in clusters occupying a relatively apical position within the pseudo-stratified epithelium in proximal intrapulmonary airways ( Fig.1E,F ). This contrasted with lower intensity and more homogenous pattern of NICD labeling outside the clusters. The expression in clusters was reminiscent of the distribution of Ascl1 (mouse achaete-scute complex homologue 1, Mash1), a bHLH transcription factor essential for NE cell fate and a marker for presumptive neuroepithelial bodies (pNEBs) (15) . Double IHC confirmed the presence of the NICD clusters juxtaposed to and distinct from Ascl1-expressing cells ( Fig. 1F ). At this stage most, if not all, clusters of NICD were juxtaposed to pNEBs. By E18.5 NICD was detected throughout the airway epithelium and in clusters associated with pNEBs. (Fig. 1G ). Previous studies have suggested that Ascl1 (E13.5) is the earliest marker for airway differentiation (15) . We conclude that Notch signaling is activated in the developing airway epithelium prior to any of the known markers of differentiation and is activated around pNEBs from early stages.
NEB-associated cells show distinct phenotypic features during development suggestive of a subpopulation of Clara cell precursors
The early onset of Notch activation in the developing lung suggested that the determination of the Clara cell fate initiates earlier than the expression of Ccsp and led us to search for early markers. Previous studies showed that Scgb3a2, another member of the secretoglobin gene family, is also expressed in secretory Clara cells of developing airways (8, 14, 16, 17) . This led us to investigate whether Scgb3a2 correlates with Notch activation at early stages. In situ hybridization (ISH) revealed Scgb3a2 expression from E12.5 onwards; expression was localized to the trachea and extrapulmonary bronchi ( Fig. 2A ). Scgb3a2 expression became stronger and expanded to lobar bronchi at E13.5-14.5 and was widespread by E18.5 ( Fig. 2 .B-D). At E14.5 Scgb3a2 was strongly expressed in clusters of cells in proximal airways ( Fig.2C ). Double ISH-IHC and confocal analysis of E14.5 lungs confirmed co-localization of Scgb3a2 and NICD ( Fig. 2E ). Co-localization was not restricted to these cell clusters but was harder to detect elsewhere in the epithelium due to the weaker NICD signals.
We tested whether clusters of Scgb3a2 positive cells were arising at sites of Ascl1expressing cells, as seen for NICD. Sections from E13.5 -E18.5 lungs were labeled with a Scgb3a2 riboprobe and an anti Ascl1 antibody. At E14.5, Scgb3a2 signals were present in the expected uniform and clustered patterns ( Fig. 2F ); 70-80% of the Scgb3a2-expressing clusters were associated with the Ascl1-expressing cell clusters. Confocal microscopy confirmed that cells expressing Scgb3a2 or Ascl1 were distinct and in direct contact. (Fig. 2G ). Interestingly, analysis of E13.5-E14.5 lungs showed a P-D pattern of pNEB formation in intrapulmonary airways, preceding the local appearance of Scgb3a2 (Fig. 2H) .
These data show that the pNEB-microenvironment at E14.5 consists of clusters of Ascl1expressing cells and another cell population expressing high levels of NICD and Scgb3a2. No Foxj1 labeling was detected in these cells at any of the stages studied. Therefore, we hypothesized that the NEB microenvironment is a niche for Clara cell precursors and examined the distribution of Ccsp in the NEB microenvironment at E18.5. However, simultaneous labeling of NICD/Ccsp/Ascl1 at E18.5 demonstrated that cells clustered around NEBs had high levels of NICD but low to negligible levels of Ccsp ( Fig. 2I -O) Three-color labeling of Scgb3a2 (ISH)/Ccsp (ISH)/Cgrp (IHC) (Calcitonin gene-related peptide, another NE cell marker) confirmed that cells in the pNEB microenvironment continue to express Scgb3a2 at this stage and have low to negligible levels of Ccsp. Our data suggested that cells associated with NEBs are a distinct set of Clara cell progenitors.
High levels of Uroplakin 3A (Upk3a) expression distinguishes secretory precursors in the NEB microenvironment
The absence of secretory cells in the airways of Notch signaling-deficient mice presented a unique opportunity to screen for additional markers enriched in the developing Clara cells. Thus, we compared the global gene expression profile of E18.5 lungs from control and mutant mice in which the Rbpjk gene was disrupted in the airway epithelium (Shh-Cre;Rbpjk Flox/Flox , or Rbpjk cnull ) (18) . As expected, genes associated with the Clara cell phenotype, such as Ccsp, Scgb3a2 and Cyp2f2 were expressed at significantly higher levels in control lungs (Fig. 3A) . A comprehensive description of this screen will be reported elsewhere. Importantly, this screen identified Uroplakin 3a (Upk3a, Fig. 3A ) as a putative marker of Clara precursors. Upk3a encodes a single-pass transmembrane domain-containing protein of the Uroplakin family that is expressed in the urinary bladder epithelium (19, 20) . Mice deficient in Upk3a have compromised urothelial permeability but no phenotype has been described in the lung (19) .
We examined Upk3a expression in control and Rbpjk cnull mice by ISH ( Fig. 3B ,C). In E18.5 controls Upk3a was highly enriched in cell clusters in the proximal airways, although signals could be also detected at lower levels in scattered cells in the distal airway epithelium ( Fig. 3B , bracket). This differed from the widespread expression patterns of Scgb3a2 and Ccsp at E18.5 (Fig. 2 ). Upk3a signals were undetectable in airways of Rbpjk cnull mice ( Fig. 3C ).
Developmental analysis of Upk3a expression using ISH and quantitative Real-time PCR (qPCR) detected signals at E12.5 (qPCR) and 14.5 (ISH), and showed increasing levels thereafter ( Fig. 3D-F ). ISH revealed clustered distribution from early stages and prompted us to investigate the relationship of Upk3a-expressing cells with pNEBs. Double ISH (Upk3a)/IHC (Ascl1) showed that Upk3a-expressing cells were juxtaposed to the Ascl1-labeled clusters from the earliest stages ( Fig.3E-F ). Quantitative analysis showed that between 70-80% of pNEBs at E14.5 were associated with Upk3a clusters. Next we investigated whether Upk3a-expressing cells were present in the NEB microenvironment in the adult lung. Double ISH/IHC using a Upk3a-riboprobe and an anti-Cgrp antibody showed at least 1-5 Upk3a-expressing cells in association with 50% of all NEBs examined ( Fig. 3G ).
Since Cyp2f2 has been reported as marker for Clara cells (17) and was also identified by our expression profiling as downregulated in Notch-deficient airways, we characterized its developmental pattern of expression. ISH showed Cyp2f2 expression throughout the epithelium of the trachea and extrapulmonary airways from E13.5 and expanded to distal airways at later times (Suppl. Fig.1A,B ). To determine the spatial relationships among Scgb3a2, Upk3a, Cyp2f2 and pNEBs, serial sections were labeled with these riboprobes and subsequently stained with an anti-Ascl1 antiserum. Analysis of E14.5 lungs showed that the pNEB-associated cell clusters that typically express strong Scgb3a2 and Upk3a signals, had little, if any, Cyp2f2 (Suppl. Fig.1C -E). This contrasted with the strong Cyp2f2 signals in neighboring Scgb3a2 positive cells. At E18.5 this subpopulation could be distinguished by strong Upk3a but not by low Cyp2f2 expression as seen at earlier times (Suppl. Fig. 1F ).
The NEB microenvironment harbors a subset of Clara cell precursor in developing airways
Next we asked whether the features identified in the pNEB-associated cells were dependent on the pNEBs. Previous studies show that neither solitary NE cells nor NEBs form in Ascl1 null mice (13, 15) . Given the small numbers of cells in the pNEB microenvironment and paucity of specific markers for these cells, we reasoned that the ablation of these cells would have escaped detection and reexamined the Ascl1 null mice. Analysis of these mutants at E14.5 showed that, in the absence of pNEBs, the clustered expression of NICD and Scgb3a2 was abolished, although the weak, non-clustered signals remained in proximal airways (Suppl. Fig.  2A -D). At E18.5, the strong expression of NICD and Scgb3a2 throughout the airway epithelium did not allow distinguishing differences between control and Ascl1 mutants.
We then investigated the impact of Ascl1 deletion on Upk3a. No Upk3a-labeled cell clusters were detected in Ascl1 null mutant lungs at E14.5 or E18.5 ( Fig.3H-K) . The selective loss of the Upk3a-labeled cell clusters was further supported by the presence of Upk3a signals in other structures (esophagus: Fig. 3I ) or in the scattered cells outside the NEB microenvironment ( Fig. 3K , inset) in Ascl1 mutants. The local impact of pNEB described here is agreement with the loss of SSEA-1-expressing cells in Ascl1 null mutants reported in the co-submitted manuscript by Morimoto et al. The Ascl1 phenotype contrasts with the generalized disruption of Upk3a that we found in the airways of Rbpjk cnull mice (Fig. 3C ). qPCR showed that Upk3a mRNA is abolished in Rbpjk cnull lungs both at E14.5 and E18.5 (Fig. 3L) . The observation is consistent with the inability to form Clara cells upon disruption of Notch signaling. In Ascl1 null mice, Upk3a expression was also markedly downregulated at E14.5 but only marginally decreased at 18.5 (Fig. 3L) . The more dramatic reduction in Upk3a transcripts seen at E14.5 mutants was expected since at this stage Upk3a-expressing cells formed essentially around pNEBs. Later, the contribution of non-pNEB associated cells minimized the differences in Upk3a expression between control and Ascl1 mutants (see also Suppl. Fig.2 E-G for Scgb3a2). These results suggest that NEBs are required to induce if not maintain a population of cells expressing high levels of Upk3a in its microenvironment.
The identification of Upk3a as a marker enriched in pNEB microenvironment provided us with an opportunity to examine the fate of these cells. We investigated the fate of Upk3aexpressing cells in the airways during prenatal and adult life using an Upk3aCreER T2 transgenic mouse. A single dose of Tamoxifen (see methods, Figure 4A ) was administered to Upk3aCre ER T2 ;Rosa26lacZ dams 15.5 days post coitum. Offspring were analyzed at E18.5 and at postnatal day 60. As putative Clara cell precursors, we investigated the ability of Upk3aCrelabelled cells to give rise to Clara and ciliated cells (2) . Thus, we performed double IHC/Xgal staining using antibodies against Foxj1, βTubulin IV (ciliated), and Ccsp, followed by quantitative analysis. (Fig.4) . At E18.5, while lacZ signal was detected in a small number of cells, few were double labeled with Ccsp and only a single cell was double-labeled with Foxj1. This showed that Upk3a lineage was largely uncommitted to either Clara or ciliated fates at this stage and was consistent with our IHC/ISH studies. By contrast, analysis of adult lungs showed labeling in both ciliated and Clara cells at nearly similar proportion (Ccsp: 47.2 + 3.4%.; βTubulin: 45.3 + 4.0%) ( Fig.4 J,K) . The pool of cells that are lacZ positive, Ccsp negative and lacZ positive, βTubulin negative may include cells that remained undifferentiated even in adults. Lineage-labeled cells were distributed throughout the airway epithelium and only a few of these cells were apposed to PNECs (Fig.B-G) . Analysis using the NE marker PGP9.5 showed no colocalization with lacZ (total of 69 lacZ positive cells examined). Together our data suggest that during development the pNEB microenvironment harbors a population of less mature Clara cell precursors with equal potential to become Clara or ciliated cell (see discussion).
Notch signaling regulates expression of Scgb3a2, Upk3a and Ccsp by a transcriptional mechanism
To gain further insights into the mechanisms by which Notch signaling regulates gene expression in Clara progenitors, we examined the effect of loss or gain of Notch function on expression of genes at early stages, prior to the onset of Ccsp expression. We generated mice in which Notch signaling was disrupted (Rbpjk cnull )(18)) or constitutively activated in the lung epithelium using ShhCre and Rosa-NICD transgenes (12) . Analysis of the Scgb3a2 pattern in E14.5 Rbpjk cnull lungs showed marked downregulation in extrapulmonary airways and negligible signals in intrapulmonary airways, including the cells in the pNEB microenvironment, which normally express strong Scgb3a2 (Fig 5A-B; Fig.2 ). In contrast, E14.5 ShhCreNICD mice showed widespread expression of Scgb3a2 in the airway progenitors ( Fig. 5E ). Upk3a expression was similarly modulated by Notch signaling (Fig. 5B, F) . Interestingly, we did not detect expression of the late marker Ccsp in E14.5 lungs overexpressing NICD, but strong signals were present at E18.5 (Suppl. Fig. 3A, B) . As evidenced by the morphology, NICD overexpression led to aberrantly enlarged airways. Nevertheless, these airways retained respiratory identity as they expressed Ttf1 (Fig.5C-D) .
Based on the genetic data above and our evidence establishing Scgb3a2 as an early Clara marker, we investigated whether Notch could directly regulate Scgb3a2 transcription. A screen for Rbpjk binding sites 1kb region upstream to the Transcription Start Site (TSS) of the murine Scgb3a2 promoter revealed high (YGTGRGAA) and low (RTGRGAR) affinity binding sites ( Fig.5G) (21) (22) (23) . For subsequent analysis we focused on the putative high affinity binding site. We performed electrophoretic mobility shift analysis (EMSA) using COS-1 cell nuclear extracts and oligonucleotides containing the Rbpjk high affinity binding sequence (intact, mutated); COS-1 cells are known to endogenously express Rbpjk (24) . Detection of a DNA-protein band that was supershifted with an anti-Rbpj antibody confirmed that endogenous Rbpjk can bind to this site (Fig.5H ). Next, we performed luciferase reporter assays using Scgb3a2 promoter sequences -273 bp to the TSS containing either a control (WT) or a mutated Rbpjk high affinity site. Co-transfection with an NICD-containing plasmid resulted in minimal induction of reporter activity (<2-fold). This response was similar to that elicited by cotransfection of the same construct with an expression plasmid-containing Ttf1, a known transcriptional regulator of Scgb3a2. We conclude that despite the presence of a high affinity binding site in the promoter fragment, NICD expression is insufficient to induce reporter expression ( Fig. 5I) .
Interactions between Notch and other transcription factors have been implicated in the control of gene expression during development (21, 25) . Moreover, synergistic regulation of the mouse Scgb3a2 gene by Ttf1 and other transcription factors, such as C/EBP has been previously reported (26) . We tested the possibility that NICD could act in concert with Ttf1 to transactivate the Scgb3a2 promoter ( Fig.5I ). Co-expression of Ttf1 and NICD dramatically increased reporter activity (over 40 fold). Importantly, introducing a mutation in the Rbpjk high affinity site (TTCTCACG to TTGTCTCG) nearly abolished this synergistic interaction (Fig.5I) .
We extended our promoter analysis to other Clara cell-associated genes like Upk3a and Ccsp. Both genes have multiple Rbpjk and Ttf1 binding sites in their promoters (Suppl. Fig4  and5) . Reporter assays showed that both Upk3a and Ccsp and were transactivated by NICD and Ttf1 in a synergistic manner, as observed for Scgb3a2 (Suppl . Figs 4 and 5) . Together, our data suggests a model in which Notch, in conjunction with locally expressed transcription factors, such as Ttf1, regulates gene transcription in Clara cell progenitors.
DISCUSSION
In this study we examined how Notch influences Clara cell fate specification in airway progenitors, and the influence of local microenvironment in generating diversity among Clara cell precursors during development. We provide evidence that commitment to a Clara cell fate occurs much earlier than the expression of Ccsp and we identify expression of Scgb3a2 and Notch activation as early events in a program of Clara cell differentiation. Our in vitro assays show that Notch activation alone has a minimal effect in the transactivation of genes in Clara cell progenitors but is highly effective when combined with Ttf1. This context-dependency is of biological significance since genetic studies have shown that Ttf1 is critical for the overall induction of respiratory cell fate, including secretory Clara cells (27, 28) .
Ultrastructural studies of the developing airways show the pNEB microenvironment contains a distinct population of non-neuroendocrine, non-ciliated cells (5) . Here we report that this population of pNEB-associated epithelial can be distinguished in molecular terms by the expression of markers associated with Clara cells such as NICD, Scgb3a2, Upk3a, Cyp2f2 and Ccsp. Based on the marker that is most enriched and best distinguishes this population of cells, Upk3a, we undertook a lineage study to trace their fate in Upk3aCreER T2 ; Rosa26 lacZ mice. We find that labeling at E15.5 results in lacZ expression in both Clara and ciliated cells of the adult airways at nearly the same proportion. Moreover, this lineage did not contribute to NE cells. Rawlins et al demonstrate that Scgb1a1CreER TM ; R26eYFP-expressing cells labeled at E18.5 and examined in adult life contribute to both Clara and ciliated cells (2) . Thus, our studies demonstrate that the Upk3a-expressing cells, despite expressing little Ccsp, exhibit the properties of a Scgb1a1-expressing Clara progenitor and implicate the pNEB microenvironment as a niche for Clara progenitors. It is likely that pNEBs are critical to specify or maintain the features of this subpopulation, however the identification of the NEB signals that mediate this process is beyond the scope of this work. Candidate signals present in NE cells potentially involved in these interactions include the Delta-like family of Notch ligands, or other currently uncharacterized Ascl1 targets (15) . Interestingly, lineage analysis of the Scgb1a1-expressing cells at E18.5 also demonstrates that these labeled cells contribute significantly to the ciliated lineage in the first three months of post-natal life but not significantly thereafter. In contrast, lineage labeling of Scgb1a1-expressing cells in the adult period identifies a population that contributes to the ciliated lineage throughout adult life (2) . An explanation for this disparity is that the population of Scgb1a1-expressing cells that were labeled in the embryonic period differs from the population labeled during the adult period. The identification of the Upk3a-lineage derived Clara progenitors, that remain uncommitted through embryonic development, supports this possibility.
The spatial-temporal pattern of Scgb3a2 we describe in murine airways, including its enrichment in clusters in the pNEB microenvironment is highly reminiscent of the CCSP pattern reported in developing airways of humans (29) . Although SCGB3A2 has been reported in human neonatal lungs, no information is available on its pattern at early developmental stages in humans (14) . A number of human conditions are associated with abnormal increase in NE bodies, including NE cell hyperplasia of infancy (NEHI), Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) and Bronchopulmonary dysplasia (BPD) The aberrant expansion of neuroepithelial cells in these conditions is likely to have a profound impact in the local microenvironment, as shown by the increase in the NEB-associated clusters of CCSP-expressing cells in BPD lungs (29) . Thus, further studies to better understand the mechanisms and consequences of the cellular interactions in this microenvironment have potentially high clinical significance.
MATERIALS AND METHODS
Mouse strains and models
Developmental and adult expression studies were performed on CD1 mice (Charles River). Generation and genotyping of Rbpjk conditional knockouts and Ascl1 knockouts mice have been described previously (8, 30) . Constitutive activation of Notch signaling in the developing airways was induced by breeding Shh cre/+ males to Rosa26 Notch1-ICD IRES GFP females (Jackson Laboratory); embryos expressing Notch1-ICD could be identified either by GFP expression or by diminutive tails. For lineage tracing experiments, Upk3acreER T2 (Jackson Laboratory) were bred to Rosa-26 LSL Lacz (Jackson Laboratory). For activation of βgalactosidase expression in embryonic lungs, an intraperitoneal injection of Tamoxifen in corn oil (1 mg to 40g body weight) was administered to pregnant mice at E15.5.
A detailed description of the reagents and methodologies (ISH, IHC, Real time PCR, EMSA, Site-directed mutagenesis, DNA transfections and Luciferase reporter assays) used in this work can be found in Supplemental Materials. Figure 1 : Spatial pattern of Notch activation in the developing airways. (A-G) Labeling for cleaved Notch1 (NICD, red) and Ascl1 (green) indicates that Notch signaling is activated in the airways a few days earlier than Ccsp expression is detected (E15. 5, 14) and that it is active in the NEB microenvironment from early stages. (A-B) Low levels of NICD were detected at E12.5 in trachea (Tr) and main bronchi (arrow) but no signal was detected in distal (dl) airways (shown at higher resolution B). Note strong NICD staining in the vasculature (V). (C-F) At E14.5 NICD labeling was more abundant in both the extrapulmonary airways (Tr in C, higher magnification in D) and proximal intrapulmonary airways (C, higher magnification in E), but no labeling was detected in distal airways (inset in C). (F) Clusters of strong NICD labeling in the proximal intrapulmonary airways at E14.5 are associated with clusters of Ascl1-expressing cells (arrows, airway outlined in white). Note the solitary Ascl1-expressing cells (arrowhead) further away are not associated with strong NICD labeling (F). (G) At E18.5 widespread labeling of NICD was detected in the in intrapulmonary airways including the NEB microenviroment (arrow). Lu=lung, L=lumen. Scale bar=10 um. βTubulin (I) demonstrate that these cells contribute to both Clara (H) and ciliated (I) lineages. (J-K) Quantitation of the numbers of X-gal stained cells that co-label for Clara and ciliated markers at E18.5 (Ccsp, Foxj1, n=156 airways) and in adults (Ccsp, βTubulin, n=501 airways). The Upk3a-lineage derived cells are mostly uncommitted to either Clara or ciliated fates at E18.5 but differentiate into these lineages in the peri-natal period (proportions of ciliated and clara cells in adults is shown graphically in K, mean+/-sem). See supplementary text for methods. An anti-Rbpjk antibody supershifted the labeled oligonucleotide containing the putative high affinity binding site (CTRL, Lane+ab). Note that the band that is supershifted by anti-Rbpjk was competed by co-incubation of the labeled oligonucleotide with an unlabeled CTRL oligonucleotide (cognate) but not competed by co-incubation with an unlabeled mutant oligonucleotide lacking the high affinity binding site (MUT, sequences shown below). (I) Luciferase assay examining the sufficiency of NICD and Ttf1 in the transactivation of the Scgb3a2 promoter. NICD expression alone did not significantly transactivate the Scgb3a2 promoter but co-expression of NICD and Ttf1 synergistically upregulated reporter expression. This synergistic upregulation was abolished when the high affinity Rbpjk binding site was mutated (-273mut, see G).
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